\
&
Contact us
Published on | 1 year ago
ProgrammesThe European Partnership for Personalised Medicine (EP PerMed) has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over € 36.5 Mio.
The topics of this call are the following:
Pay attention: projects focussing only on drug-drug-interaction and projects focusing on the clinical development of new drugs are not eligible.
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on how to apply can be found on the dedicated FWO webpage. Interested to apply? Contact the FWO advisors at europe@fwo.be. Deadline for pre-proposal submission AND national pre-application via the FWO e-loket is 18 February 2025, 14:00 CET.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Project SeafoodTomorrow is a project that is approved within the call BG-08-2017: Innovative sustainable solutions for improving the safety and dietary properties of seafood.
The three-year SeafoodTomorrow project brings together 34 partners. From Flanders, ILVO takes part in the project.They are responsible for setting up two databases which are the central point of the project to gather all the project data from analysis and assessement. ILVO is also leader of the workpackage dealing with authenticity, traceability and labelling. ILVO is also involved a the workpackage about novel food preparation. And in the managerial part, ILVO is head of the IPC- Intellectual Property Comité.